LGND financials

Ligand Pharmaceuticals (LGND) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

LGND income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025$268.09M–$41.00M$124.45M6.13
2024$167.13M–-$22.61M-$4.03M-0.22
2023$131.31M–$11.94M$52.15M2.94
2022$196.25M–$3.04M-$33.36M-1.98
2021$241.54M–$103.85M$57.14M3.31
2020$163.56M–$37.50M-$2.98M-0.18